46results about How to "Avoid Microbial Contamination" patented technology

A device for feeding a treatment liquid into medical appliances. The device includes an outlet opening for the treatment liquid, especially for feeding water into dental equipment, a feed line for the treatment liquid, means to introduce degerminating agents into the treatment liquid, and an on / off valve disposed upstream from an outlet opening onto which the feed line is connected. A back-flush valve is connected to the on / off valve, and a reservoir is provided for the treatment liquid, whereby the treatment liquid is transported from the reservoir with the aid of a pump. Further, a back-flush line is connectible alternatively via a drain valve to a drain or to the reservoir so that the treatment liquid is pumped into the drain, or in circulation from the reservoir through the feed line to the switch valve and through the back-flush line again into the reservoir.

Methods are provided for uniform deposition of particles on curved surfaces such as fibers and coatings formed by the particles. Particles in the size range of 10-2000 nm are deposited onto a fibrous material via electrostatic interaction between charge modified fiber material surfaces and oppositely charged particles or metal ions. Various nonmetallic, bimetallic or other charged particles are deposited onto a fibrous material via electrostatic interaction between charged modified fibrous material surfaces and oppositely charged particles. Particles can be directly assembled onto a surface of a fibrous material by controlling hydrogen bonding interactions between interfaces of fibers and functionalized particles. Metal particles can also be deposited by in situ synthesis. A method is also provided for layer-by-layer deposition of particles over a fibrous material.

This invention relates to a method, process and apparatus for disinfecting and sterilizing all types of surfaces contaminated with microorganisms and toxic substances to render both inactive. Furthermore, this invention relates to both a method and apparatus for disinfecting and / or sterilizing breathable air and then using this air to protect a confined space from external contamination. The apparatus consists of a new ultra-violet (NUV) source that is more effective than mercury based 254 nm light for destroying DNA of virus, bacteria, spores and cists. It is most effective in breaking chemical bonds in toxic gases and Biotoxins that are useful to terrorists. It is combined with other apparatus that remove particulates and byproducts sometimes produced by the NUV source and maintains positive pressure of the confined space so as to prevent the influx of air from outside the protected zone.

The use of bis-amines to enhance the antimicrobial activity of pharmaceutical compositions is described. The bis-amines are particularly useful for enhancing the antimicrobial activity of aqueous ophthalmic compositions, such as artificial tears or ocular lubricants, and solutions for disinfecting contact lenses.

Methods are provided for uniform deposition of particles on curved surfaces such as fibers and coatings formed by the particles. Particles in the size range of 10-2000 nm are deposited onto a fibrous material via electrostatic interaction between charge modified fiber material surfaces and oppositely charged particles or metal ions. Various nonmetallic, bimetallic or other charged particles are deposited onto a fibrous material via electrostatic interaction between charged modified fibrous material surfaces and oppositely charged particles. Particles can be directly assembled onto a surface of a fibrous material by controlling hydrogen bonding interactions between interfaces of fibers and functionalized particles. Metal particles can also be deposited by in situ synthesis. A method is also provided for layer-by-layer deposition of particles over a fibrous material.

The use of NIPAM polymers to prevent or reduce the formation of protein deposits on the surfaces of medical devices is described. The invention is particularly directed to reduction of the adsorption of proteins on surfaces of contact lenses and other medical prosthetics.

The present invention relates to a stabilized pemetrexed formulation, and more particularly to a stabilized pemetrexed formulation comprising acetylcysteine as antioxidant and a citrate salt as buffer.

The invention relates to a microbiological filter, comprising filtering head, gas discharge valve, discharge switch is installed on side part of filtering head, the other end of discharge valve is connected with suction channel, the filter head is equipped with cup taking device, a rotary upgoing structure is equipped between cup taking device and filtering head, the open and close of gas discharge switch is controlled through contact and separation with inner wall of cup taking device, the lower part of filter is provided with support stand, one channel- section discharging fixation structure is installed between filtering head and support stand, the bottom of support stand is equipped with suction nozzle connected with suction channel. The invention is characterized in that the filtering head is detachable, and can be cleaned and disinfected, which avoids bacteria infection, and there is no bacteria infection for filtering membrane, which guarantees good process for experiment and test accuracy.

An object of the invention is to provide an ultraviolet absorbing composition for a skin and hair, which has absorption of high absorbance in both UV-A region and UV-B region, wherein an ultraviolet absorbing compounds in the ultraviolet absorbing composition will not precipitate or turn to yellow in the process of preparing cosmetics. Moreover, the ultraviolet absorbing composition shows excellent feeling in use, and will not dye clothes easily, and may be applied to the skin and hair of a living object, and exhibits excellent capability of absorbing an ultraviolet light.The ultraviolet absorbing composition for skin and hair, which comprises the ultraviolet absorbing compound represented by formula (1) and at least one ultraviolet absorbing compound selected from the group consisting of formulae (I) to (V).(In formula (1), Y11 and Y12 each independently represents monovalent substituent. One of Y11 or Y12 is cyano group, and the other is cyano group, alkylcarbonyl group, arylcarbonyl group, heterocyclic carbonyl group, alkylsulfonyl group, or arylsulfonyl group, carbamoyl group, sulfamoyl group, alkoxycarbonyl group, and aryloxycarbonyl group. V11 and V12 each independently represents a hydrogen atom or a monovalent substituent.)

Procedure for obtaining Olea Europea extracts from Olea Europea leaves dried at less than 35° C. with alkanols at a low temperature and extract purificationNew pharmacological applications of Olea Europea extracts as an agent reinforcing cellular immunity and delayed hypersensitivity in healthy humans, activating and proliferating T-lymphocytes, Natural Killer cells, monocytes and granulocytes, and pro-inflammatory cytokins.

A system for a closed circuit forced hot air warmer of patient beds and blankets with improved sterility has a patient mattress or blanket microprocessor controlled warmer that circulates heated air in a closed system without releasing warmed air into the area surrounding the patient or into the operating room. The system helps to avoid the exposure of patients and hospital workers in the operating room to possible infecting microbes carried in unsterile turbulent air currents related to the release of air from non-closed systems. The machinery and flexible hoses of the system are initially sterilized by a microprocessor controlled antimicrobial mist generator. The system does not discharge jets of warmed air due to the closed circuit arrangement. Turbulent air flow previously produced in the vicinity of the patient by high velocity air jets is eliminated. An ambient, quiescent condition accorded by closed circuit heating prevents infection of patients and operating room personnel by microbe migration.

The present invention relates to a stabilized pemetrexed formulation, and more particularly to a stabilized pemetrexed formulation comprising acetylcysteine as antioxidant and a citrate salt as buffer.

The present invention provides aqueous ophthalmic compositions in the form of solution comprising hexanoic acid, 6-(nitrooxy)-, (1S,2E)-3-[(1R,2R,3S,5R)-2-[(2Z)-7-(ethylamino)-7-oxo-2-hepten-1-yl]-3,5-dihydroxycyclopentyl]-1-(2-phenylethyl)-2-propen-1-yl ester and macrogol 15 hydroxystearate as the only solubilizing agent, and a method for their preparation.

A method of protecting an insertion site permitting passage of a transcutaneous medical device into a patient. The method includes grasping a dressing device, positioning the dressing device over the insertion site, and adhering the dressing device to the patient over the insertion site. The dressing device may include a moisture vapor permeable backing, a polyurethane foam matrix, and an adhesive. The polyurethane foam matrix may be adhered to a first side of the moisture vapor permeable backing, and the adhesive may cover a second side of the moisture vapor permeable backing opposite of the first side. The polyurethane foam matrix can include a polyanhydroglucuronic acid or salt thereof in an amount to achieve a haemostatic effect, and chlorhexidine di-gluconate in an amount of 9% to 16% (w / w) to achieve an antimicrobial effect without adversely affecting wound healing.